Delisting Notice · Reg FD Disclosure

BIO-key International, Inc. received a notice from Nasdaq on June 5, 2026, stating that the Company had not filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026, which serves as an additional basis for delisting its common stock from the Nasdaq Capital Market. A hearing is scheduled for June 16, 2026, to consider the Company's continued listing.